top of page

Click on the Poster to View Larger

Search by
Poster Number

Poster 8

Kelley Tangredi
Jun 11, 2024
1 min read

Updated: Jun 27, 2024

Efficacy of the oral JAK1/JAK2 inhibitor deuruxolitinib in adult patients with moderate-to-severe alopecia areata: Pooled results from the multinational double-blind, placebo-controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 trials

Authors: Maryanne Makredes Senna; Brett King; Natasha A. Mesinkovska; Arash Mostaghimi; Colleen Hamilton; James Cassella

<PREVIOUS POSTER | NEXT POSTER>

Poster 8

01, 02, 03, 04, 05, 06, 07, 08, 09, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64

bottom of page